LifePro Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $447K | Sell |
4,524
-266
| -6% | -$26.3K | 0.27% | 85 |
|
|
2024
Q2 | $444K | Sell |
4,790
-465
| -9% | -$43.1K | 0.32% | 69 |
|
|
2024
Q1 | $499K | Sell |
5,255
-77
| -1% | -$7.31K | 0.33% | 67 |
|
|
2023
Q4 | $476K | Buy |
5,332
+272
| +5% | +$24.3K | 0.37% | 62 |
|
|
2023
Q3 | $369K | Buy |
5,060
+1,908
| +61% | +$139K | 0.3% | 67 |
|
|
2023
Q2 | $262K | Sell |
3,152
-1,116
| -26% | -$92.9K | 0.2% | 88 |
|
|
2023
Q1 | $354K | Hold |
4,268
| – | – | 0.26% | 75 |
|
|
2022
Q4 | $354K | Sell |
4,268
-1,988
| -32% | -$165K | 0.26% | 75 |
|
|
2022
Q3 | $496K | Sell |
6,256
-94,605
| -94% | -$7.5M | 0.29% | 38 |
|
|
2022
Q2 | $7.49M | Buy |
+100,861
| New | +$7.49M | 3.88% | 1 |
|